Cell-sized cannabis factories could soon be producing medical treatments for epilepsy. A non-psychoactive compound found in marijuana plants called cannabidivarin (CBDV) has shown promise in the treatment of severe cases of epilepsy. However, to treat just 10 per cent of people with epilepsy would require around 1500 tonnes of pure CBDV. To obtain this amount using current methods, you would need to plant large quantities of marijuana and extract their small supply of CBDV.
© 2001-2025 Fundación Dialnet · Todos los derechos reservados